Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard V Williams

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Regulatory Toxicology and Pharmacology : RTP|April 8, 2017
Carbamates and ICH M7 classification: Making use of expert knowledgeRachel Hemingway, Adrian Fowkes, Richard V Williams
Mutagenesis|October 23, 2018
Important considerations for the validation of QSAR models for in vitro mutagenicityAlex Cayley, Adrian Fowkes, Richard V Williams
Expert Opinion on Drug Metabolism & Toxicology|September 25, 2012
Latest advances in computational genotoxicity predictionRussell T Naven, Nigel Greene, Richard V Williams
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 7, 2002
Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunctionRichard V Williams, Lloyd Y Tani, Robert E Shaddy
JACC. Case Reports|July 28, 2021
A Rare Case of Epicardial Lead Strangulation of Left Ventricular InflowJuan C Samayoa, Susan P Etheridge, Richard V Williams
Regulatory Toxicology and Pharmacology : RTP|May 28, 2017
Utility of published DNA reactivity alertsAlun Myden, Sebastien J Guesne, Alex Cayley, et al.
The American Journal of Cardiology|May 25, 2010
Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?Rachel T McCandless, L Luann Minich, Lloyd Y Tani, et al.
The American Journal of Cardiology|October 11, 2005
Ventricular remodeling in children with left ventricular dysfunction secondary to various cardiomyopathiesLloyd Y Tani, L LuAnn Minich, Richard V Williams, et al.
Pediatrics|January 5, 2002
Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?Richard V Williams, Venus M Wilke, Lloyd Y Tani, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 11, 2002
Echocardiographic diagnosis of coronary sinus ostial atresiaJames J Paul, Richard V Williams, L Lu Ann Minich, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Regulatory Toxicology and Pharmacology : RTP|April 8, 2017
Carbamates and ICH M7 classification: Making use of expert knowledgeRachel Hemingway, Adrian Fowkes, Richard V Williams
Mutagenesis|October 23, 2018
Important considerations for the validation of QSAR models for in vitro mutagenicityAlex Cayley, Adrian Fowkes, Richard V Williams
Expert Opinion on Drug Metabolism & Toxicology|September 25, 2012
Latest advances in computational genotoxicity predictionRussell T Naven, Nigel Greene, Richard V Williams
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 7, 2002
Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunctionRichard V Williams, Lloyd Y Tani, Robert E Shaddy
JACC. Case Reports|July 28, 2021
A Rare Case of Epicardial Lead Strangulation of Left Ventricular InflowJuan C Samayoa, Susan P Etheridge, Richard V Williams
Regulatory Toxicology and Pharmacology : RTP|May 28, 2017
Utility of published DNA reactivity alertsAlun Myden, Sebastien J Guesne, Alex Cayley, et al.
The American Journal of Cardiology|May 25, 2010
Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?Rachel T McCandless, L Luann Minich, Lloyd Y Tani, et al.
The American Journal of Cardiology|October 11, 2005
Ventricular remodeling in children with left ventricular dysfunction secondary to various cardiomyopathiesLloyd Y Tani, L LuAnn Minich, Richard V Williams, et al.
Pediatrics|January 5, 2002
Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?Richard V Williams, Venus M Wilke, Lloyd Y Tani, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 11, 2002
Echocardiographic diagnosis of coronary sinus ostial atresiaJames J Paul, Richard V Williams, L Lu Ann Minich, et al.
Pageof 8